The nasal version of the Oxford/AstraZeneca COVID-19 vaccine failed an early-stage clinical trial, dashing hopes for better infection prevention and forcing researchers to re-think the design.
#people #back #researchers #participants #press-release #effectiveness #astrazeneca-vaccine #vaccinated-people #clinical-trials #spike-protein
[
add
]
[
|
|
...
]